多参数MRI上优势前列腺内肿瘤病灶的容积测量:序列间与观察者间差异
回顾性分析41例前列腺癌患者的治疗前多参数MRI,由观察者手动勾画优势前列腺内病灶并比较不同序列间及观察者间的体积差异,同时与根治性前列腺切除标本组织学体积对照。T2W MRI体积观察者间一致性较好且与组织学最接近,DW-MRI与DCE-MRI体积及其与T2W的体积比在不同Gleason分级间无差异。
要点
- T2W MRI上优势前列腺内病灶体积的观察者间一致性界限为0.9与-1.1 cm³,变异性低。
- T2W MRI体积较固定标本组织学体积高估(观察者1 +33%,观察者2 +16%)。
- DW-MRI与DCE-MRI体积较组织学体积低估,DCE-MRI低估更明显(观察者1 -32%,观察者2 -79%)。
核心结论
- T2W MRI上优势前列腺内病灶体积观察者间变异性低且与组织学一致,提示其适合用于放疗计划中大体肿瘤体积的勾画;DW-MRI代表的细胞性肿瘤体积大于DCE-MRI代表的血管性异常,两者与T2W体积之比不受Gleason评分影响。
研究设计与样本
- 回顾性研究,纳入41例接受前列腺切除术(队列1)或根治性放疗(队列2)且治疗前有多参数MRI(T2W MRI、DW-MRI、DCE-MRI)的前列腺癌男性,观察者间比较n=40可分析,与根治性前列腺切除标本比较n=20。
关键影像表现/征象
- 优势前列腺内病灶在各序列上手动勾画,观察者间体积一致性界限:T2W MRI 0.9与-1.1 cm³,DW-MRI 1.3与-1.7 cm³,DCE-MRI 0.74与-0.89 cm³。
- 队列1中T2W体积较固定标本组织学体积高估(观察者1 +33%,观察者2 +16%),DW-MRI与DCE-MRI体积低估组织学体积,DCE-MRI低估更明显(观察者1 -32%,观察者2 -79%)。
- T2W、DW-与DCE-MRI体积间差异显著(p < 10⁻⁸)。
诊断标准与关键数值
- DW-MRI体积与T2W体积之比:观察者1 73.9 ± 18.1%,观察者2 72.5 ± 21.9%;DCE-MRI体积与T2W体积之比:观察者1 42.6 ± 24.6%,观察者2 34.3 ± 24.9%,两者差异显著(p < 10⁻⁸)。
- 上述体积比在Gleason 3+3、3+4与4+3或更高分级间无差异。
临床应用与阅片要点
- T2W MRI上勾画优势前列腺内病灶体积观察者间变异性低且与组织学一致,作者认为其适合用于放疗计划中大体肿瘤体积的勾画。
- DW-MRI代表的细胞性肿瘤体积大于DCE-MRI代表的血管性异常,两者与T2W体积之比不受Gleason评分影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To establish the interobserver reproducibility of tumour volumetry on individual multiparametric (mp) prostate MRI sequences, validate measurements with histology and determine whether functional to morphological volume ratios reflect Gleason score.
METHODS: 41 males with prostate cancer treated with prostatectomy (Cohort 1) or radical radiotherapy (Cohort 2), who had pre-treatment mpMRI [T2 weighted (T2W) MRI, diffusion-weighted (DW)-MRI and dynamic contrast-enhanced (DCE)-MRI], were studied retrospectively. Dominant intraprostatic lesions (DIPLs) were manually delineated on each sequence and volumes were compared between observers (n = 40 analyzable) and with radical prostatectomy (n = 20). Volume ratios of DW-MRI and DCE-MRI to T2W MRI were documented and compared between Gleason grade 3 + 3, 3 + 4 and 4 + 3 or greater categories.
RESULTS: Limits of agreement of DIPL volumes between observers were: T2W MRI 0.9, -1.1 cm3, DW-MRI 1.3, -1.7 cm3 and DCE-MRI 0.74, -0.89 cm3. In Cohort 1, T2W volumes overestimated fixed specimen histological volumes (+33% Observer 1, +16% Observer 2); DW- and DCE-MRI underestimated histological volume, the latter markedly so (-32% Observer 1, -79% Observer 2). Differences between T2W, DW- and DCE-MRI volumes were significant (p < 10-8). The ratio of DW-MRI volume (73.9 ± 18.1% Observer 1, 72.5 ± 21.9% Observer 2) and DCE-MRI volume (42.6 ± 24.6% Observer 1, 34.3 ± 24.9% Observer 2) to T2W volume was significantly different (p < 10-8), but these volume ratios did not differ between the Gleason grades.
CONCLUSION: The low variability of the DIPL volume on T2W MRI between Observers and agreement with histology indicates its suitability for delineation of gross tumour volume for radiotherapy planning. The volume of cellular tumour represented by DW-MRI is greater than the vascular (DCE) abnormality; ratios of both to T2W volume are independent of Gleason score. Advances in knowledge: (1) Manual volume measurement of tumour is reproducible within 1 cm3 between observers on all sequences, confirming suitability across observers for radiotherapy planning. (2) Volumes derived on T2W MRI most accurately represent in vivo lesion volumes. (3) The proportion of cellular (DW-MRI) or vascular (DCE-MRI) volume to morphological (T2W MRI) volume is not affected by Gleason score.
引用
- Harvey H, Orton MR, Morgan VA, et al. Volumetry of the dominant intraprostatic tumour lesion: intersequence and interobserver differences on multiparametric MRI. Br J Radiol. 2017. PMID: 28055249. doi:10.1259/bjr.20160416
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。